Chairman’s Address at the NeuRizer 2023 AGM
11 November 2023
Neurizer News
Topics cover include:
Read More
Entitlement Issue Prospectus
3 November 2023
Neurizer News
We have released an updated Entitlement Issue Prospectus document and the related Target Market Determination. Please use the links below to access both of these.
Read More
NeuRizer September 2023 Quarterly Report
27 October 2023
Neurizer News
NeuRizer’ September 2023 Quarterly Activities Report is now available. Key points to note are:
Read More
NeuRizer Executive Chairman Interview
19 October 2023
Neurizer News
NeuRizer Executive Chairman Justyn Peters has recently recorded an interview to update shareholders. This 21 minute interview is based on NeuRizer’s recent corporate update of 18 September ...
Read More
Alan Kohler Interview with NRZ Exec Chair
15 August 2023
Neurizer News
NeuRizer Executive Chairman Justyn Peters was recently interviewed by prominent Australian financial Journalist, Alan Kohler. In this wide ranging interview a variety of topics were covered: The ...
Read More
Conversation 3 with NeuRizer Ltd Executive Chairman, Justyn Peters
25 June 2023
Neurizer News
The third in a series of conversations with NeuRizer Executive Chairman, Justyn Peters
Read More
NeuRizer Achieves Major Milestone in Assessment Process for the NRUP
19 June 2023
Neurizer News
NeuRizer is pleased to announce that a significant milestone in the approval process for Stage 2 of the NeuRizer Urea Project (“NRUP”) has been achieved. The ...
Read More
All things Hydrogen with NRZ Executive Chairman, Justyn Peters
7 June 2023
Neurizer News
NRZ Executive Chairman, Justyn Peters, has updated shareholders in a conversation where he discussed the recently announced Hydrogen JV with Meijin Energy Investments:
Read More
NeuRizer opens up significant new revenue stream with China hydrogen deal
6 June 2023
Neurizer News
NeuRizer Ltd chairman Justyn Peters discusses with Proactive a recent deal the company has agreed with Meijin Energy Investments – the largest integrated hydrogen company in China. Following ...
Read More
Main Menu
This data is delayed by 20 minutes